Evofem Biosciences Inc (EVFM)
0.0132
0.00 (0.00%)
USD |
OTCM |
Nov 05, 11:00
Evofem Biosciences Shareholders Equity (Quarterly): -64.63M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -64.63M |
| March 31, 2024 | -66.03M |
| December 31, 2023 | -66.51M |
| September 30, 2023 | -54.56M |
| June 30, 2023 | -55.66M |
| March 31, 2023 | -56.40M |
| December 31, 2022 | -71.80M |
| September 30, 2022 | -78.04M |
| June 30, 2022 | -216.00M |
| March 31, 2022 | -128.10M |
| December 31, 2021 | -99.58M |
| September 30, 2021 | -58.83M |
| June 30, 2021 | 8.964M |
| March 31, 2021 | -13.64M |
| December 31, 2020 | 1.347M |
| September 30, 2020 | 40.21M |
| June 30, 2020 | 68.54M |
| March 31, 2020 | 1.021M |
| December 31, 2019 | 15.64M |
| September 30, 2019 | 24.08M |
| June 30, 2019 | 35.79M |
| Date | Value |
|---|---|
| March 31, 2019 | -28.85M |
| December 31, 2018 | -23.36M |
| September 30, 2018 | -10.06M |
| June 30, 2018 | 5.258M |
| March 31, 2018 | -18.29M |
| December 31, 2017 | -99.68M |
| September 30, 2017 | 4.850M |
| June 30, 2017 | 6.513M |
| March 31, 2017 | 9.035M |
| December 31, 2016 | 11.91M |
| September 30, 2016 | 13.77M |
| June 30, 2016 | 16.04M |
| March 31, 2016 | 18.50M |
| December 31, 2015 | 23.81M |
| September 30, 2015 | 32.73M |
| June 30, 2015 | 49.58M |
| March 31, 2015 | 58.64M |
| December 31, 2014 | 65.25M |
| September 30, 2014 | 10.52M |
| December 31, 2013 | -6.019M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-216.00M
Minimum
Jun 2022
68.54M
Maximum
Jun 2020
-47.06M
Average
-56.40M
Median
Mar 2023
Shareholders Equity (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.617M |
| Palatin Technologies Inc | -0.1115M |
| iBio Inc | 21.32M |
| Theriva Biologics Inc | 27.65M |
| Oragenics Inc | 1.326M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.551M |
| Total Liabilities (Quarterly) | 73.18M |
| Debt to Equity Ratio | -0.6697 |
| Current Ratio | 0.0986 |
| Net Debt Paydown Yield | 169.2% |